ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $873,179 | -17.2% | 160,219 | +1.9% | 0.00% | 0.0% |
Q2 2023 | $1,055,147 | +66978.6% | 157,250 | -11.8% | 0.00% | -50.0% |
Q1 2023 | $1,573 | +19.7% | 178,197 | +3.6% | 0.00% | 0.0% |
Q4 2022 | $1,314 | -99.9% | 172,014 | +0.9% | 0.00% | 0.0% |
Q3 2022 | $1,214,000 | -6.4% | 170,464 | +6.3% | 0.00% | 0.0% |
Q2 2022 | $1,297,000 | -2.9% | 160,373 | +66.6% | 0.00% | 0.0% |
Q1 2022 | $1,336,000 | -53.9% | 96,252 | -6.8% | 0.00% | -50.0% |
Q4 2021 | $2,897,000 | -13.5% | 103,228 | +4.8% | 0.00% | -20.0% |
Q3 2021 | $3,348,000 | -17.9% | 98,489 | -1.3% | 0.01% | 0.0% |
Q2 2021 | $4,079,000 | +32.1% | 99,818 | +30.2% | 0.01% | +25.0% |
Q1 2021 | $3,087,000 | -39.2% | 76,682 | -10.8% | 0.00% | -42.9% |
Q4 2020 | $5,081,000 | +24.4% | 85,928 | +2.3% | 0.01% | +16.7% |
Q3 2020 | $4,085,000 | +5.3% | 84,000 | +4.7% | 0.01% | 0.0% |
Q2 2020 | $3,881,000 | +132.7% | 80,225 | +33.6% | 0.01% | +100.0% |
Q1 2020 | $1,668,000 | +255.7% | 60,046 | +283.4% | 0.00% | +200.0% |
Q4 2019 | $469,000 | +33.6% | 15,660 | +37.7% | 0.00% | 0.0% |
Q3 2019 | $351,000 | – | 11,369 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |